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Conditioned  hemagglutination,  that  is,  modification  of  the  agglutinative 
properties of erythrocytes by adsorption of bacterial antigens, has been widely 
explored during the past decade. This technique has been applied to a  variety 
of bacterial antigens  and it is now well established  that most bacterial poly- 
saccharides, when admixed with washed red cells are readily and firmly adsorbed 
on the surface conferring on the erythrocytes an additional antigenic specificity, 
that of the adsorbed bacterial antigen (2). 
While this technique has aroused great interest and has gained general acceptance, 
most investigations have been directed largely towards specific antigenic components 
adsorbed on the erythrocyte and the numerous practical applications of the test. On 
the other hand, it apparently has not been generally appreciated that the fixation on 
the red cell surface of bacterial antigens might exert an effect on the reactivity of the 
red cell due to its native antigens, as well as other properties of the cell related to the 
general phenomenon of agglutination. 
While  studying  the  basic  phenomenon  underlying  fixation  of  certain  bacterial 
antigens on red cells, Ceppellini and De Gregorio  (3, 4) observed that crude extracts 
of Vi strains of Salmonella typhosa interfered with agglutinability of human red cells 
by anti-blood group sera. However, it was not established with certainty whether the 
inhibitory effect was due to the Vi antigen itself or to some other bacterial component. 
The inhibitory action of bacterial polysaccharides on viral hemagglufination has 
been reported by a number of workers. The situations in which the effect was observed 
were as  follows:  Klebslella type B  polysacchaxide  on  hemagglutinafion by mumps 
virus  (5);  fractions derived  from Vi  strains of S.  typhosa on hemagglutination  by 
influenza  virus (6); Klebsiella polysaccharides on hemagglutination by influenza  virus 
(7); and S. typhosa polysaccharide preparations on hemagglutination by myxo- and 
polyoma viruses (8). 
The  objective  of  the  present  work  was  to  determine  the  identity  of  the 
bacterial component responsible for the suppression of blood group agglutina- 
tion and to ascertain the mechanism of this phenomenon. The studies reported 
here show that this attribute is shared by a number of capsular polysaccharides 
* A preliminary report of these findings  was presented at the 42nd Meeting of the American 
Association of Immunologists, Philadelphia, April, 1958 (1). 
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which impart  to  the red cell surface some of  their peculiar physicochemical 
characteristics. As a consequence there is produced a non-specific stabilization 
of erythrocyte suspensions, 
Materials and Methods 
Capsular Polysaccharides.--The  Vi antigens from Escherichia coli 5396/38, Paracdobaarum 
ballemp  7851/39,  and Salmonella typhosa Ty 2 were those prepared  by Webster et al.  (9). 
Capsular polysaccharides were isolated from cultures of types A and B Klebsidla pneumonia, 
by the method of Goebel and Avery (10). The Type III pneumococcus polysaccharide was 
kindly provided by Dr. M. Heidelberger. This preparation was distinctive in that it was the 
only one, of a total of 9, that adsorbed on red blood cells for conditioned hemagglutination 
(11). 
Somatic Lipopolysaccharides.--These were prepared from S. typhosa, ttaemophilus perturbs, 
Proteus vulgaris, and Shigdla  paradysonteria~ by our colleague Dr. M. E. Webster, employing 
a  modification of the Boivin procedure. The polysaccharides from Pseudomonas aeruginosa 
(12),  Serratia  marc~c~as  (13),  and  from  Pasteurdta  tularensis  (14)  were  contributed 
by Dr. L.  Ginger, Dr.  M.  J.  Shear,  and  Dr.  G.  G. Wright.  These preparations  had been 
previously examined with regard to their uptake by erythrocytes for hemagglutination by 
specific antibacterial sera (11). 
In this report polysaccharides which depress or inhibit agglutination of erythrocytes by 
blood group antisera or viruses will be designated as "active" polysaccharides. Preparations 
which,  although  adsorbed  and  effectively contributing  their own serological specificity to 
the red cell, do not affect blood group or virus hemagglutination will be referred to as 'qn- 
active" polysaccharides. 
Antisera.--The majority of bacterial antisera were prepared  by intensive immunization 
of rabbits with the various microorganisms from which the aforementioned polysaccharides 
had been obtained. The pneumococcus antiserum was a  concentrated  immune globulin of 
rabbit derivation prepared by the Lederle Laboratories, Pearl River, New York. The anti-A 
and  anfi-B  sera  contained  natural  human  agglutininins;  anti-H was  extracted from  Ulex 
europacus; anti-M  and anti-N  were commercial products prepared in  rabbits;  and  anti-P 
contained a natural horse agglutinln. "Anti-human"  serum was a potent unadsorbed serum 
prepared by immunization of rabbits with human erythrocytes. Other specific antisera for the 
remaining  blood  group  agglutinogens were  of human  origin obtained  from  "immunized" 
individuals (pregnancy or transfusion).  Sera containing heterophile antibody were obtained 
from patients with infectious mononucleosis. The anti-sheep amboceptor was commercially 
prepared. 
Viruses.--Influenza, Newcastle, and mumps viruses were lyophilized allantoic fluids har- 
vested from infected chick embryos. 
Erythrocytes.--The  majority  of  tests  were  conducted  with  erythrocytes  from  human 
donors, collected and preserved in modified Alsever solution. Sheep cells,  similarly collected 
and preserved, were utilized in a few instances. The preserved cells generally were used be- 
tween 3 and 12 days after bleeding. 
Coating of Erythrocytes with Polysaccharides.--For uptake of polysaccharides, erythrocytes 
were washed 3 times with 10 volumes of 0.85 per cent sodium chloride, made up to a  10 per 
cent suspension, and mixed with an equal volume of polysaccharide dissolved in saline at the 
desired concentration. Such mixtures were incubated for 2 hours at 37°C, washed 3 times to 
remove unadsorbed polysaccharide, and, unless otherwise indicated, made up to a  1 per cent 
suspension for test.  As given in the experimental section, the quantities of polysaccharide 
refer to a  1 per cent suspension of erythrocytes, e.g. where a  10 per cent red cell suspension ~'I~W YOBK  61,  iIEW XORK 
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was mixed with an equal volume of 100 micrograms polysaccharide per ml, the cells (adjusted 
to a  1 per cent suspension) are referred to as having been treated  with  10 micrograms of 
polysaccharide per ml. 
Baavrial HcmagglutinaHon.--All bacterial polysaccharides used in this work were shown 
to  be  fixed on  red  cells as  evidenced by  conditioned  hemagglutination  with  appro- 
priate homologous antibacterial  sera. The details of the technique and its application have 
been reviewed by Neter (2). 
Blood Group and Virus Hemagglutination.--For blood grouping the standard  techniques 
were employed for different systems and kinds of antibodies; el. Race and Sanger (15). Except 
for special situations the procedure employed for the titration  of antisera was as follows: 
a 5 per cent red cell suspension  was used mixed with an equal amount of antibody dilution, 
incubated at the appropriate temperature, centrifuged for 1~/~ minutes at 140 g, and agglutina- 
tion read macroscopically after gentle shaking of the tube. Various degrees of agglutination 
were expressed by number with  5 representing maximum agglutination  (a single clump), 
and 1 as fine agglutination, barely visible to the naked eye. For virus hemagglutination the 
technique employed was the widely used procedure described by Salk (16). 
EXPEBTM~.NTAL 
The availability of isolated Vi antigen, freed of other bacterial components, 
enabled us  to  demonstrate promptly that  this  bacterial  polysaccharide  was, 
indeed,  the agent in bacterial extracts responsible for the suppression of blood 
group agglutinability. The type of effect on hemagglutination brought about by 
coating red  cells with  Vi  antigen  is  presented  in  Table  I.  Untreated  human 
group  A  erythrocytes  were  agglutinated  to  a  titer  of  1:512  by  the  anti-A 
serum.  When  these  erythrocytes  were  coated  with  different  amounts  of  Vi 
antigen,  the titer of the antiserum decreased progressively until agglutination 
had been completely suppressed; i.e., even undiluted serum failed to agglutinate 
these  cells.  The  possibility  that  the  bacterial  preparations  neutralized  the 
anti-A agglutinins was disproved early in these studies. 
Screening  of Bacterial  Polysaccharides for Activity.--It  was not practical  to 
examine in detail each individual agglutinating system; instead human anti-A 
or influenza virus were used, against human group A erythrocytes, in a  dose 4 
times the dilution  representing  the agglutination  end point; i.e., 4  units.  For 
each polysaccharide, levels of  250,  50,  and  10/~g  were used  to  coat  the  test 
red cells. This provided a sensitive test; under these conditions products which 
did not inhibit could be excluded with assurance as being inactive. 
The results of this survey are summarized in Table II; SSS  III, Klebsiella 
types  A  and  B,  polysaccharides,  and  Vi  antigens  derived  from  E.  coli,  P. 
ballerup, and S. typhosa were active at each of the levels tested. In contrast the 
other  products,  which  are  somatic  antigens  (endotoxins)  of  various  Gram- 
negative bacteria, did not inhibit hemagglutination to any significant degree. 
The inhibitory action was studied  quantitatively with 3  Vi products,  inas- 
much as they had previously been shown to differ primarily as regards  their 
physical state;  the  coli  and  ballerup  polysaccharides werd more highly poly- 
merized than  the product from S.  typhosa  (9). Human group A  erythrocytes 324  BLOOD  GROUP  AOGLUTINABILITY 
were treated with dilutions of these Vi antigens ranging from 1 to 100/zg and 
set up with doubling dilutions of the appropriate reagents for each of 3 aggluti- 
nating systems. Some of the results of these tests are given in Table III where 
the values represent the reciprocal of the altered endpoint of the agglutinating 
agent toward cells treated with Vi antigen at the indicated levels. Similar tests 
with SSS III showed that on a weight basis its activity was comparable to that 
of the S. typhosa  Vi polysaccharide. For each of the 3 systems the magnitude 
of the effect was proportional to the concentration of polysaccharide used for 
TABLE  I 
Vi Inhibition of Blood Group A Agglutination 
Agglutination of Vi-coated cells 
Treatment of 
human group A1 
red  cells with  coli  Dilutions of anti-A serum (human group B) 
Vi antigen 
1:4  1:8  1:32 
~g 
0 
1 
3 
7 
10 
20 
40 
80 
1  1:2 
5  5 
5  5 
5  5 
5  5 
5  5 
5  5 
2  1 
0  0 
1:64  1:128 
5  5 
5  4 
5  2 
5  1 
1  0 
0  0 
0  0 
0  0 
1:256  1:512 
4  1 
2  1 
1  0 
0  0 
0  0 
0  0 
0  0 
0  0 
Test conditions: 2 hour 
1000 m,~. 
Agglutination: 5, 4, 3, 2, 
nation. 
incubation at 20°C; read macroscopically after 1~ minutes at 
1 represent decreasing strength of agglutination; 0 =  no aggluti- 
coating the erythrocytes and inversely proportional to the titer of the aggluti- 
nating agent. 
Inhibition of Blood Group Agglutinability.--To determine whether the inhibi- 
tory effect of the Vi antigen varied with different blood group systems, erythro- 
cytes from donors known to possess a variety of antigenic combinations were 
treated with coli Vi antigen (125/zg/ml of 1 per cent red cell suspension) and 
retested  with  potent  blood  group-typing  sera  according  to  the  appropriate 
technique. The following antisera were used: human natural anti-A and anti-B; 
rabbit anti-M  and  anti-S;  horse natural  anti-P;  human  immune  anti-D,  C, 
c, E, Fy  a, and K; lectins of anti-A and anti-H specificity obtained from Lima 
and Ulex. In all cases agglutination was now completely suppressed. 
To  determine  whether  this  inhibition  was  quantitatively  similar  for  the 
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conditions of test where the titer of the different antibodies was equalized to 8 
agglutinating units, using human A B serum as diluent. These antibodies were 
tested  against  erythrocytes  sensitized  with  decreasing  amounts  of  Vi  poly- 
saccharide in order to' determine the minimum inhibitory dose of Vi for each 
blood group system.  Erythrocytes  treated with 2  to 4  #g of coli Vi were no 
longer  agglutinated  by  the  test  antisera  (Table  IV),  showing  that  all blood 
TABLE  II 
Effect  of Various Bacterial Polysaccharides on ttemagglutination 
Polysaccharides fixed on erythrocytes 
Source 
Escherichia coli 08 
Escherichia  coli 0127 
Haemophilus pertussls 
Pasteurdla tularensis 
Proteus vulgaris 
Pseudomonas aeruginosa 
Salmonella typhosa 0901 
Serratia marcescens 
Skigdla paradysenteriae 
Diplococcus pneumoniae Type III 
Escherichia coli 5396/38 
Klebsidla  pneumoniae A 
Klebsidla pneumoniae B 
Paracolobactrum ballerup 
Salmonella typhosa Ty 2 
Type 
Somati-~-:- 
Somatic  ] 
Somatic  ] 
Somatic  I 
Somatic  I 
Somatic  I 
Somatic 
Somatic 
Somatic 
Capsular 
Capsular 
Capsular 
Capsular 
Capsular 
Capsular 
Agglutinating systems 
Anti-human serum  (rabbit)  Influenza virus (PR-8) 
Polysaccharide treatment of red cells 
250/,tg 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
50 tt 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
lO~tg  250 l~g 
+  + 
+  + 
+  % 
+  + 
+  + 
+  + 
%  + 
+  + 
+  % 
+  - 
50/~g 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
lO #g 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+  Indicates discernible agglutination by 4 agglutinating units; i.e., no inhibition. 
-- Indicates no discernible agglutination by 4 agglutinating units; i.e., inhibition. 
group  receptors  tested were equally  susceptible  to inhibition  by Vi  polysac- 
charide. 
Both natural and immune antibodies, and human, animal, or plant reagents, 
were made equally ineffective. Because there is some basic difference between 
the saline agglutinins  and  the so-called  incomplete  antibodies  it was desired 
to compare them. Accordingly, two sera of anti-D specificity, one of the saline 
type and the other of the incomplete variety,  showing the same titer against 
Rh-positive  cells  (when tested  in saline and aJbumin  respectively),  were also 
titrated  with  these  cells  which had  been  coated  with  Vi  polysaccharide.  In 
both cases, in addition to saline agglutination, the three techniques in common 326  BLOOD GROUP AGGLUTINABILITY 
use  for  detecting  incomplete  antibodies  were  applied;  namely,  20  per  cent 
bovine albumin  as  suspending  medium, pretreatment  of the  ceils  with  ficin, 
and the indirect Coombs test. Treatment of the cells with 50 #g of Vi antigen 
suppressed the activity of both varieties of antisera.  The characteristic effect 
of Vi was manifest despite the varied serological techniques employed. It was 
noted that treatment of the red cells with ficin (or trypsin) neither prevented 
TABLE III 
Inhibition of Hen;agglutination by Different Vi Polysaccharldes 
Hemagglutinating systems 
Isoanti-A 
(titer,~ 512) 
Rabbit anti-human 
(titer,:~ 4000) 
Influenza virus 
(titer,:~ 640) 
"liters following treatment of red cells with Vl antigen 
Source 
Vi 
concentration* 
E. toll  P. ballerup  S.  typhosa 
100 
40 
10 
3 
1 
100 
40 
10 
3 
1 
100 
40 
10 
3 
1 
0 
0 
1 
32 
64 
0 
0 
0 
64 
128 
0 
0 
20 
160 
320 
0 
0 
2 
16 
128 
0 
0 
0 
32 
256 
0 
0 
40 
80 
320 
16 
64 
128 
256 
512 
32 
128 
512 
2000 
40O0 
80 
320 
640 
640 
640 
* Amount of Vi used for coating, expressed as /zg/ml of a 1 per cent red cell suspension. 
:~ The fiter for each system refers to that obtained with untreated human type A, erythro- 
cytes. 
the  adsorption  of  Vi  antigen  nor  brought  about  its  release.  The  fact  that 
incomplete  antibodies  per  se  do not  clump  the  red  cells  made  possible  the 
coating of erythrocytes with Vi polysaccharide after they had  been sensitized 
with the anti-D antibody. Also,  in this case the subsequent use  of techniques 
for the detection of incomplete antibodies did not bring about  agglutination. 
Multiple  Layer  (Lattice)  Test.--The fact that Rh-positive cells,  previously 
sensitized with a  strong incomplete anti-D  serum,  and then  treated with Vi 
polysaccharide were  not  agglutinated  upon  addition  of  antiglobulin  serum, 
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antibody  uptake.  However,  other  possibilities  such  as  the  displacement  or 
release of the previously fixed antibody, were not excluded. To clarify this issue 
it was  decided to use the multiple layer technique as  described by Coombs 
and coworkers (17). This technique seemed to be particularly suited for deter- 
mining whether the Rh antibody was still present on Vi-coated erythrocytes. 
Rh-positive red cells were sensitized with 3 levels (1:4,  1:16, and 1:64) of an 
incomplete anfi-D serum which gave a  titer of 1:512 against normal erythro- 
cytes. The cells were then washed, treated with 125/zg of coli Vi polysaccharide, 
washed, treated with antiglobulin (15 minutes at room temperature), washed 3 
Quantitative Corn 
Blood  group 
Anti-A 
Anti-B 
Anti-C 
Anti-E 
Anti-P 
Anti-D 
Anti-D 
Anti-K 
TABLE IV 
~arison of  Vi  lnkibition  of  tteraagglutination for  Different  Blood Groups 
Amount of Vi used for coating, expressed  as Dg/ml 
of 1 per cent red cells suspension 
0 
0 
1 
0 
0 
0 
0 
0 
0.5 
Saline§ 
Saline 
Saline 
Saline 
Saline 
Saline 
Incomplete 
Incomplete 
Red cells: human Ab B, C, D, E e, P+, Kk. 
* All reagents brought to 8 agglutinating units upon dilution with AB serum. Complete 
antibodies tested in saline; incomplete antibodies tested with antiglobulin serum. 
§ Subsequent application of antiglobulln technique to red cells which failed to be aggluti- 
nated by complete antibodies did not bring about agglutination. 
times, and treated with human gamma globulin (15 minutes at room tempera- 
ture); then again washed 3  times and mixed with a  fresh aliquot of the anti- 
globnlln serum; this cycle was repeated until agglutination occurred. 
In replicate experiments the agglutination of the Rh-sensitized cells appeared 
between the 4th and 5th globulin-antiglobulin cycles. This showed that the Vi 
treatment had neither prevented uptake nor displaced  the anti-D  antibody. 
In fact, in another similar experiment, the cells were first treated with Vi and 
then  the  anti-Rh  antibody.  The  antiglobulin  serum  had  a  titer  of  1:1024 
against  Rh-positive cells fully sensitized  with  incomplete anti-D  and,  when 
used in  the  experiment, was  diluted  1:20.  The concentration of the human 
gamma globulin (10 #g/ml) was  selected as  representing 4 times the minimal 
amount able to neutralize the 1: 20 antiglobulin serum. To avoid building up of 
globulin-antiglobulin chains not specifically founded on the anti-Rh antibody, 328  BLOOD  GROUP  AGGLUTINABILITY 
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all reagents used were repeatedly absorbed both with normal and with Vi-coated 
human red cells. To rule out non-specific reactions, the following controls were 
employed: (a)  in the treatment of aliquots of the cells, normal rabbit serum 
was substituted for the human globulin or the immune antiglobulin, (b)  ceils 
were included which initially had not been sensitized with anti-D,  (c)  after 
t 
I 
I 
I 
"""  RED  CELL  MEMBRANE 
RED CELL  MEMBRANE  WITH  Rh  RECEPTORS 
"IF"  RED  CELL  MEMBRANE PLUS ANTI-Rh  GAMMA GLOBULIN 
O  NON-SPECIFIC  HUMAN GAMMA GLOBULIN 
II  RABBIT ANTIBODY  TO  HUMAN  GAMMA  GLOBULIN 
-~-  IONIC HALO  BEFORE  TREATMENT  WITH  Vi POLYSACCHARIDE 
•  '  "  IONIC HALO  AFTER  TREATMENT  WITH  Vi POLYSACCHARIDE 
FIG. I. Schematic diagram of multiple layer (lattice) experiment. 
each globulin-anfiglobulin treatment, a portion of the cells were fitrated with 
an anti-Vi and an anti-A serum; the former agglutinated to titer while the 
latter  was  completely suppressed,  showing that  Vi was  still present and in 
concentration suificient to inhibit blood group agglutination. This experiment 
is s-mmarized in Table V and is freely interpreted in Fig.  1. The finding that 
specific agglutination was obtained after 4 or more cycles, is attributed to the 
building up of a globulin-antiglobulin lattice, with the original anti-D antibody 
as the foundation, thus providing conclusive evidence for adsorption of anti-D 
antibody by Vi-treated Rh-positive red ceils. 330  BLOOD GROUP AGGLUTINABILITY 
Absorption  and  Elution  of  Blood  Group  Antibodies.--The  results  of  the 
multiple layer test, which showed that antibody was indeed fixed on Vi-treated 
erythrocytes,  were  further  reinforced  1 by  a  direct  measure  of  the  antibody 
absorbed by and eluted from Vi-treated red cells. For this purpose aliquots of 
human anti-A (group B) serum were incubated  (with repeated shaking) for 2 
hours  at  room  temperature  with  equal  amounts  of  human  erythrocytes  of 
Group A1, and these cells treated with different concentrations of Vi polysac- 
charide.  As a  control, similar absorptions were carried out with group O  cells, 
Vi-treated and normal. Vi-treated group A1 cells were able to absorb a  signifi- 
cant amount of antibody as compared with group O controls, but, on a quanti- 
tative  basis,  consistently  less  than  the  A1 untreated  cells.  The  cells  used for 
absorption were then washed, resuspended in equal volumes of A B serum  s and 
then kept  at 56°C for 20 minutes.  A  significant amount of antibody was re- 
covered from the  A1 cells,  both  Vi-treated  and  normal,  but  not from the  O 
cells; the amount of anti-A recovered from treated and normal A1 cells did not 
differ  significantly.  In similar  experiments  with  R_h-positive  cells  and  anti-D 
incomplete  serum  (indirect  Coombs  test)  Vi-treated  and  normal  cells  were 
found to absorb equal amounts of antibody. 
Viral Hemagglutination.--Early in this  work it became apparent  that viral 
hemagglutination  was  sensitive  to  inhibition  by  the  same  polysaccharides 
which were "active"  in suppressing  blood group agglutination.  Treatment  of 
human or chicken red cells with as little as 1/zg of coli Vi significantly reduced 
the hemagglutination  end point of influenza,  mumps,  and NVD viruses,  and 
40/zg suppressed agglutination entirely. Just as for blood group agglutinabillty, 
the extent of this inhibition  was proportional to the concentration of Vi used 
for  coating  the  red  cells  (Table  III).  These  results  are  in  accord  with  the 
lit  was  observed  that  fixation  of  Vi  on  red  cells had  little,  if  any,  effect  on 
immune hemolysis. In titrations  of rabbit anti-sheep hemolysin with an excess of complement, 
the titer was reduced from 1:28,000 for untreated cells to 1:10,750 for cells treated  with 
25 #g of coli Vi. In another experiment, sheep red cells were first sensitized with 4 100 per cent 
units of hemolysin, washed, and divided into 2 aliquots, one of which  was coated with 25 
/~g of Vi; both suspensions gave the same titer of complement. Moreover, when aliquots of 
anti-sheep  hemolysin, with a titer of 1:28,000 were absorbed with Vi-treated  and normal 
erythrocytes respectively, the Vi-treated cells reduced the titer to 1: 5120, while the untreated 
cells brought it down to 1:320. 
Experiments such as these showed that, despite the presence of Vi polysaccharide, antibody 
in amount adequate  to bring  about hemolysis was able to reach receptors  on the red cell 
surface.  Unlike  hemagglutination,  where  the  second phase  of the reaction  is  suppressed, 
antibody attached to receptors on the red cell permits complement to be oriented on the cell 
surface  and lysis ensues. Diminished  absorption  of hemolysin by Vi-treated  cells may be 
related  to the known heterogeneity,  in molecular size, of rabbit anti-sheep hemolysin (t9). 
Since Vi was partly eluted along with the antibody,  and might therefore interfere with 
the subsequent  titration of the ehiate,  A B serum was used as the eluting medium; in this 
way uptake of Vi by the test cells was prevented by the inhibitor in human serum (18). RUGGEROCEPPELLINIANDMAURICELANDY  331 
findings of MacPherson  et al.  (7)  and  Zhdanov et ol.  (8),  who  reported that 
capsular polysaccharide preparations from Klebsiella aerogenes, and S. typhosa, 
adsorbed on red cells, inhibited hemagglutination by a  group of viruses. 
Inhibition  of Conditioned  (Bacterial)  Hemagglutination.--A  variety of bac- 
terial polysaccharides appear to be adsorbed on red cells with approximately 
equal facility; the order in which these substances are applied may be varied 
at will (2). 
Heretofore no interference of one polysaccharide with the activity of the others has been 
reported (11). However,  the concentration of antigens employed was, as a rule, lower than 
those used in the present work in which 1 ml aliquots of a 10 per cent suspension of human 
type O washed erythrocytes  were incubated with 1 ml (1 rag) of each of a number of individual 
bacterial polysaccharides.  Following 2 hours' incubation at 37°C the cells were  washed  as 
usual, an aliquot of each suspension made up to 1 per cent and reserved for subsequent titra- 
tion with the homologous antibacterial serum. The remainder of each of the cell suspensions 
was incubated with an equal volume of Vi antigen (300/~g/ml), washed,  and diluted to a 
1 per cent suspension for test. Thus the 1 per cent suspensions used in these tests had been 
exposed  to 100/zg/ml of the various test polysaccharides and 30/zg/ml of Vi antigen. In 
some experiments the order was reversed and in still others both antigens were applied simul- 
taneously. The reactivity of singly and  doubly treated erythrocytes toward homologous 
antibacterial serum was then compared. 
The results of the most pertinent experiments are summarized in Table VI 
which  shows  that  the  reactivity of  bacterial  antigens  fixed  on  the  red  cell 
surface was markedly depressed by Vi antigen, just as were receptors indigenous 
to  the  red  cell.  The  inhibition  of  conditioned  hemagglutination  generally 
required  concentrations  of  Vi  antigen  higher  than  those  which  sufficed  to 
affect blood group  reactivity (taking into account  the  titer of the reagents). 
It  is  noteworthy  that  the  bacterial  polysaccharides  which  were  markedly 
affected by Vi, were "inactive" with regard to inhibition of blood group hemag- 
glutinafion.*  In  contrast,  the  capsular  polysaccharides which  were  "active" 
with  regard to blood group  agglutination were practically unaffected  by Vi; 
the implications of this finding for a  general interpretation of the Vi effect is 
considered elsewhere in this communication. 
Alteration in the Physical Properties of Polysaccharide-Treated Erythrocytes.-- 
It remained to be determined, other than by immunological methods, whether 
8 For its special bearing in theinterpretation  of the phenomenon of "0 inagglutinability"  in 
viable Salmonella typhosa we have previously reported on the reciprocal interference of Vi 
and 0 Salmonella antigens when adsorbed on erythrocytes simultaneously  or in either sequence 
(20). Reduction in O agglutinabillty occurred,  which became more pronounced as the level 
of Vi antigen was increased in relation to the amount of O. The possibility  is recognized that 
treatment with high dosage of different polysaccharides may lead to a partial displacement 
as suggested by Spaun (21). However, the fact that inhibition of hemagglutination, by poly- 
saccharides such as Vi, is common to systems as varied as blood groups and viruses as well 
as conditioned bacterial hemagglutination, points toward a common mechanism  essentially 
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the fixation of "active" polysaccharides on red cells brought about changes in 
the  physical properties  of the  red  cell  surface.  The  techniques  available  for 
ascertaining  such  changes  were  sedimentation  rate,  acid  agglutination,  and 
electrophoretic mobility of the treated cells. 
(a)  Sedimentation  Rate.-- 
Saline at pH 7, human plasma from subjects with high and low sedimentation  rate and a 
dextran  preparation  of  160,000 molecular  weight  (dextravan,  British  Drug House)  were 
employed as suspending media. Erythrocytes,  treated as usual with different concentrations 
of various bacterial polysaccharides and washed, were made up to 20 per cent suspensions in 
these  media,  dispensed into Wintrobe  tubes,  and allowed to settle  at  room temperature. 
Sedimentation,  in millimeters, was recorded at intervals  between 30 minutes and 24 hours. 
TABLE VI 
Effect of Vi Polysaccharide on Conditioned (Bacterial) Hemagglutination 
Treatment of erythrocytes 
Homologous polysaccharide 
Homologous  polysaccharide  fol- 
lowed by Vi (coli) 
Hemagglutinsfion titers of specific antibacterial  sera tested 
with erythrocytes costed with polysaccharide  derived from 
Salmonella 
typhosa 
2560 
80 
Pseudo- 
~0~$ 
aeruginas 
Serralia 
m@fcs$c~*t$ 
480 
0 
Escher- 
ichia coli 
Diplococ~ 
monlae 
Type III 
7680 
384O 
Klebsiella 
moniae 
Group A 
3840 
3840 
The rate of sedimentation  of normal as well as polysaccharide-treated  cells 
varied  considerably  with  the  different  suspending  media,  being  slowest  in 
saline and most rapid in the dextran.  However, in a  general way, the relative 
effects  of the various  polysaccharides  on sedimentation  were  comparable for 
all suspending media. Since the constitution of plasma is variable, v/z., content 
of fibrinogen,  and  presence  of small  amounts  of antibodies  for  the  polysac- 
charides  under  test,  most of the  comparisons were made with  dextran.  Only 
those  polysaccharides  which  had  been  shown  to  affect  specific agglutination 
likewise  stabilized  the  cell  suspension  (Table  VII).  Vi  polysaccharide  (coli) 
was  by far  the  most  effective agent  in modifying the  sedimentation  rate  of 
red cells. Thus, cells treated with as little as 3 #g of Vi (per  ml of 20 per cent 
suspension)  were  still  in  suspension  24  hours  later.  Indeed  these  Vi-treated 
cells stayed in suspension over a  period of days until they eventually lysed. 
(b)  Acid Agglutination.-- 
Normal and polysaccharide-treated  erythrocytes were suspended in a final concentration 
of 1 per cent in buffered saline at pH values extending from pH 3 to 8 by 0.2 pH increments 
as described by MacPherson (7). Agglutination patterns were read after standing for 1 hour at 
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Those polysaccharides which  affected specific  agglutination and  the  sedi- 
mentation rate of the erythrocytes also decreased acid agglutination. In effect, 
such polysaccharide-treated cells  were stable at a  lower pH than controls or 
cells coated with "inactive" polysaccharides. It is noteworthy that Vi-treated 
cells are stable in solution down to pH 4.4,  a value which lies in the range of 
the isoelectric point of the Vi polysaccharide, while normal cells are stable only 
as low as pH 5.6, which is in the range of the isoelectric point of the normal 
red cell surface. 
(c) Electrophoretic Mobility.--Human  erythrocytes,  both  untreated  and 
treated with 50/zg of coli Vi were made up to a  1 per cent suspension in 0.1 M 
phosphate buffer, pH 7.4,  containing 0.26 per cent NaCI. The U tubes (0.075 
TABLE VII 
Effect of Polysacckarides  on Rate of Sedimentation of Erythrocytes 
Treatment of erythrocytes 
Bacterial  polysaccharides 
None 
Typhoid O 
SSS-III 
Kleb. pneumoniae type B 
Vi (coli) 
Vi (coli) 
Vi (coU) 
/~g/ml of 20 per 
cent suspension* 
1000 
1000 
200 
12 
6 
3 
Sedimentation 
hours 
1  4 
ff~m  mfn 
84  86 
84  86 
1  1 
1  1 
0  0 
0  1 
0  1 
mm 
86 
87 
86 
87 
4 
6 
10 
* Suspending medium "DEXTRAVAN" (BDH). 
cm  ~ cross-sectional area) of the Tiselius apparatus were filled with the suspen- 
sions and a  current of 13.5 ma applied. The migration for normal cells  was 
0.003  cm/minutes, while that for the Vi-coated cells  was 0.012  cm/minutes 
toward the anode.  4 This was clear evidence of a  marked increase in negative 
charge of the red cell surface as a consequence of the presence of Vi. 
DISCUSSION 
The results of this investigation have shown that by adsorption of certain 
bacterial  polysaccharides  on  erythrocytes  their  characteristic  agglutinative 
properties can be completely suppressed. The "active" polysaccharides, which 
inhibited hemagglutination, are viscous, highly polymerized capsular antigens, 
characterized by their  content of sugar acids  (uronic acid),  and carrying a 
4 We are indebted to Dr. P. R. Anderson, Walter Reed Army Institute of Research, for 
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marked negative charge.  The Vi polysaccharide consists  entirely of repeating 
units of N-acetyl d-galactosaminuronic acid (22); SSS III is made up of d-glu- 
curonic  acid +  d-glucose  (23); the Klebsiella polysaccharides contain d-glucu- 
ronic acid +  glucose  +  fucose (24).  The  "inactive" products  Oil the other 
hand,  are  the  somatic  (endotoxic)  components  of  Gram-negative  bacteria, 
which are high  molecular weight lipopolysaccharide complexes,  with a  weak 
negative charge.  The "active" acidic polymers are believed to be long thread- 
like molecules, whereas the "inactive" somatic complexes are probably globular. 
It is noteworthy that  the capsular polysaccharides are taken up directly by 
erythrocytes; in contrast, prior treatment of the somatic antigens with heat or 
alkali is required to effect their fixation  on red cells. The nature of the attach- 
ment of these antigens to the red cell surface is not known. 
The active polysaccharides differ considerably as regards their capacity, on a 
weight basis,  to inhibit. The relative potencies of the Vi products, which were 
maintained  in a  consistent fashion in  the various hemagglutinating  systems 
tested, correspond to differences in their physical and immunogenic attributes 
(25).  Additional  information  has recently been obtained which confirms  the 
correlation  between  specific  viscosity  of  the  Vi  polysaccharides  and  their 
capacity to suppress hemagglutination (26). Preparations of Vi antigen isolated 
from  E.  coli  by  chemical  fractionation  (Webster)  and  by  electrophoresis 
(Jarvis),  displayed the same specificity and  analytical values. However, the 
specific viscosity of Vi-J was 3 times that of Vi-W, and its capacity to suppress 
anti-A  hemagglutination  was  also  3-fold  greater  than  Vi-W;  i.e.,  specific 
viscosity and suppressive activities of Vi-J were increased in exactly the same 
ratio. 
Hemagglutinafion by antibody (and by analogy, hemagglufination by virus 
as well) is regarded as occurring  in two distinct stages: (a) uptake of antibody 
by specific receptors, (b) subsequent clumping of the sensitized  cells. The latter 
stage is variously interpreted as the result of an antigen-antibody lattice (the 
antibody being bivalent) which "bridges" the cells (27), or, as primarily involv- 
ing changes  in electrical  charge and therefore "solubility" of the cell surface, 
as suggested by Gard (28).  The former hypothesis is now generally accepted, 
at least for some kinds of agglutinating  antibodies. However, no explanation 
has been given why albumin in the suspending medium brings about aggluti- 
nation by some kinds of incomplete antibodies (e.g. Rh, but not Kell). For the 
present it appears that the "completeness" or "incompleteness" of the aggluti- 
nation phenomenon is the result of interplay between three major factors: (a) 
the valency and size of the antibody molecule;  (b) the location of the receptors 
on the red cell surface, and the physical status of the cell surface itself; (c) the 
characteristics  of  the  suspending  medium.  The  observations  of  Moskowitz 
and  Carb  (29)  may be pertinent,  chiefly  as regards  (b).  They reported  the 
suppression of ABO blood group agglutinability following formalin treatment 
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In evaluating possible mechanisms of the inhibitory effect of polysaccharides 
there  are  two  major  alternatives.  The  active  polysaccharides  prevent  the 
uptake of antibody by the cell, or, the antibody is fixed on the cell as usual, but 
the polysaccharide has changed the physical status of the cell surface in such 
a way that the fixed antibody no longer can bring about dumping of the cells. 
The present work has provided data which have a bearing on both hypoth- 
eses. Thus, it was found that the Vi-treated cells do adsorb antibody and virus 
particles.  For instance,  with hemolytic systems no significant  difference  was 
found between the reactivity of Vi-treated and normal cells. Moreover, inhibi- 
tion of the  Coombs reaction was obtained when the red cells had fixed  the 
incomplete anti-D antibody before treatment with Vi. Proof that the anti-D 
had not been displaced by the polysaccharide was obtained by means of the 
multiple layer antiglobulin technique. In fact, Vi-treated cells were agglutinated 
to titer when multiple layers of globulin and antiglobulin were applied alterna- 
tively (Table V). This would seem to rule out the possibility that the "active" 
polysaccharides blanket or otherwise hinder red cell receptors. The results of 
this test are of particular significance for the understanding of the phenomenon 
because they indicate that in the presence of Via higher layer of globulin (alter- 
nating human globulin and anti-human  globulin)  is necessary to bring about 
agglutination.  It is therefore visualized (Fig.  1) that the action of Vi consists 
primarily of extending the ionic halo which normally keeps the cell in "solu- 
tion" (Gard, 28) or, according to the lattice theory, there is a wider gap to be 
bridged by the globulin. 
It is noteworthy that Vi depressed conditioned agglutinabflity involving a 
variety of bacterial polysaccharides except for SSS III and Klebsiella type A, 
the only other products tested which share the physicochemical characteristics 
of Vi. This observation suggests that the level of accessibility of the receptors, 
relative to that of the Vi molecule, may be decisive. As regards antibody uptake 
by Vi-treated cells, in some systems such as rabbit anti-human  hemolysin and 
incomplete anti-D, uptake was quite unaffected, while in other systems such as 
group A "non-immune" anti-A the amount of antibody fixed by the Vi-treated 
cells was somewhat diminished.  It should be noted, however, that incomplete 
anti-D  and some non-immune  anti-A  differ  in  their  physical characteristics, 
chiefly as regards molecular size  (30).  It is a  reasonable assumption that di- 
minished  uptake involves only  19  S  antibodies,  but this  remains  to  be de- 
termined experimentally. Finally, attention is directed toward the parallelism 
in the inhibition by Vi of immune hemagglutination  and the altered physical 
properties of the cell as shown in experiments on sedimentation rate, acid ag- 
glutination and the altered physical properties of the cell as shown in experi- 
ments on sedimentation rate, acid agglutination, and electrophoretic mobility. 
The relationship between these two sets of phenomena is probably based on the 
orientation assumed by these acidic polymers when fixed on the red cell surface: 
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medium has  two major consequences;  v/z., stabilization of the cell suspension 
and the inhibition of lattice formation. 
There exist naturally occurring  situations which bear a resemblance to the 
coating of erythrocytes with polysaccharides obviously not indigenous  to the 
red cell surface; for example,  the Lewis antigens in man (31), the J  antigen in 
cattle (32),  and the R  antigen in sheep (33). The human Lewis antigens are 
not known to affect the general agglutinability of the red cell; on the other hand 
the so-called inagglutinabflity of cells of some individual oxen (Coombs) may be 
related to the uptake in rivo of a  soluble substance not unlike  the "active" 
polysaccharides alluded to in this report. 
The distinctive stabilizing  effect of the Vi polysaccharide may be used to ad- 
vantage in a number of hematological and immunological  problems where it is 
desirable to avoid the second stage of agglutination. In the test for the rheum- 
toid factor and for the detection of antigenic specificifies of human antibodies, 
agglutinating antibody could be used in place of incomplete antibody for coat- 
ing  the  carrier  erythrocytes.  In  the  study  of  hemolytic  systems  it  may 
be desirable to avoid agglutination without impairing uptake of antibody. In 
fact, Vi inagglutinability may provide a  convenient means of transforming a 
"complete" antigen-antibody reaction to one which is "incomplete."  Finally, 
an  even  broader  application  of  this  effect  may  be  foreseen  for  sta- 
bilizing a variety of mammalian cells such as platelets, leucocytes, and isolated 
tissue cells (34) which,  because of their tendency to clump spontaneously, are 
subjected to serologic tests with great difficulty.  In addition to such practical 
applications there is little doubt that this unique action of the Vi polysaccharide 
could provide a  useful approach  to achieving  a  better understanding  of the 
basic mechanism of agglutination and other cell-surface phenomena. 
SUMMARY 
Erythrocytes coated with bacterial capsular polysaccharides, notably the Vi 
antigen, were no longer agglutinated by antibodies directed against the various 
antigens native to the red cell surface. These effects could not be attributed to 
prevention of antibody uptake even though in some systems the uptake of anti- 
body was diminished.  In fact, agglutination  by R.h-incomplete  antibody was 
brought back to the original  titer only after the sensitized  Vi-coated cells had 
been  subjected  to  ten  alternating  exposures  to  globulin  and  antiglobulin. 
Hemagglutination by Newcastle, mumps, and influenza  viruses was also sup- 
pressed. Erythrocytes coated with Vi polysaccharide assumed the distinctive 
physicochemical attributes of this acidic polymer which results in a stabiliza- 
tion of the erythrocyte suspension as manifested by increased electrophoretic 
mobility and a striking decrease in the rate of sedimentation. Among the possi- 
ble models for explaining  the nature of the Vi effect on immune agglutination, 
the data favor interference with lattice formation. EUGGERO  CEPPELLINI AND  ~AURICE  LANDY  337 
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